C23H23ClN6O2
Neat
450.93
ent-Suvorexant; 1030377-80-0; 5-chloro-2-[(5S)-5-methyl-4-[5-methyl-2-(2H-1, 2, 3-triazol-2-yl)benzoyl]-1, 4-diazepan-1-yl]-1, 3-benzoxazole; Suvorexant, (S)-; Suvorexant Impurity 1; RG9V4Z2QSY; SCHEMBL1820881; SCHEMBL29596480; (S)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1, 4-diazepan-1-yl)(5-methyl-2-(2H-1, 2, 3-triazol-2-yl)phenyl)methanone; [(7S)-4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1, 4-diazepin-1-yl][5-methyl-2-(2H-1, 2 and 3-triazol-2-yl)phenyl]methanone
[(7S)-4-(5-chloro-1, 3-benzoxazol-2-yl)-7-methyl-1 and 4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m0/s1